Limhamn, Sweden

Maria Carmen Valcarce Lopez


Average Co-Inventor Count = 15.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maria Carmen Valcarce Lopez: Innovator in Therapeutic Agents

Introduction

Maria Carmen Valcarce Lopez is a prominent inventor based in Limhamn, Sweden. She has made significant contributions to the field of therapeutic agents, particularly through her innovative work on aryl carbonyl derivatives. With a total of 2 patents, her research focuses on enhancing glucokinase activity, which is crucial for managing various diseases.

Latest Patents

Maria Carmen Valcarce Lopez's latest patents include groundbreaking inventions related to aryl carbonyl derivatives. These derivatives serve as activators of glucokinase, which may be beneficial for the management, treatment, control, or adjunct treatment of diseases where increasing glucokinase activity is advantageous. Her work in this area has the potential to impact therapeutic strategies significantly.

Career Highlights

Maria is currently associated with Novo Nordisk A/S, a leading global healthcare company. Her role at Novo Nordisk allows her to contribute to the development of innovative solutions in diabetes care and other therapeutic areas. Her expertise and dedication to research have positioned her as a valuable asset in the field of pharmaceutical innovation.

Collaborations

Throughout her career, Maria has collaborated with esteemed colleagues, including Dharma Rao Polisetti and Janos Tibor Kodra. These collaborations have fostered a dynamic exchange of ideas and have enhanced the quality of her research.

Conclusion

Maria Carmen Valcarce Lopez exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to therapeutic agents and her commitment to advancing medical science are commendable. Her work continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…